Reported Earlier, Enliven Therapeutics Prices Upsized Public Offering Of 8,933,334 Common Shares At $37.50, Pre-Funded Warrants At $37.499, Expects $400M Proceeds

Loading news article.

Reported Earlier, Enliven Therapeutics Prices Upsized Public Offering Of 8,933,334 Common Shares At $37.50, Pre-Funded Warrants At $37.499, Expects $400M Proceeds | WAPE

Reported Earlier, Enliven Therapeutics Prices Upsized Public Offering Of 8,933,334 Common Shares At $37.50, Pre-Funded Warrants At $37.499, Expects $400M Proceeds

Article summary

Related companies

Comments —